XML 59 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value
9 Months Ended
Nov. 30, 2014
Fair Value  
Fair Value

Note 13 - Fair Value

 

The fair value hierarchy of our financial assets and liabilities carried at fair value and measured on a recurring basis is as follows:

 

FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES

(in thousands)

 

 

 

 

 

Quoted Prices in

 

Significant Other

 

 

 

 

 

 

Active Markets

 

Observable

 

 

 

 

Fair Values at

 

for Identical Assets

 

Market Inputs

 

Description

 

 

November 30, 2014

 

(Level 1)

 

(Level 2)

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

Money market accounts

 

 

$

370 

 

$

370 

 

$

-    

 

Foreign currency contracts

 

 

162 

 

-    

 

162 

 

Total assets

 

 

$

532 

 

$

370 

 

$

162 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

Long-term debt - fixed rate (1)

 

 

$

82,674 

 

$

-    

 

$

82,674 

 

Long-term debt - floating rate

 

 

35,707 

 

-    

 

35,707 

 

Total liabilities

 

 

$

118,381 

 

$

-    

 

$

118,381 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices in

 

Significant Other

 

 

 

 

 

 

Active Markets

 

Observable

 

 

 

 

Fair Values at

 

for Identical Assets

 

Market Inputs

 

Description

 

 

February 28, 2014

 

(Level 1)

 

(Level 2)

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

Money market accounts

 

 

$

1,549 

 

$

1,549 

 

$

-    

 

Foreign currency contracts

 

 

-    

 

-    

 

-    

 

Total assets

 

 

$

1,549 

 

$

1,549 

 

$

-    

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

Long-term debt - fixed rate (1)

 

 

$

83,951 

 

$

-    

 

$

83,951 

 

Long-term debt - floating rate

 

 

112,607 

 

-    

 

112,607 

 

Interest rate swaps and foreign currency contracts

 

 

1,596 

 

-    

 

1,596 

 

Total liabilities

 

 

$

198,154 

 

$

-    

 

$

198,154 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

 

The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items. Money market accounts are included in cash and cash equivalents in the accompanying consolidated condensed balance sheets and are classified as Level 1 items.

 

We classify our fixed and floating rate debt as Level 2 liabilities because the estimation of the fair market value of these financial liabilities requires the use of discount rates based upon current market rates of interest for debt with comparable remaining terms. Such comparable rates are significant other observable market inputs. The fair market value of the fixed rate debt was computed using a discounted cash flow analysis and discount rates of 1.76 percent at November 30, 2014 and 1.75 percent at February 28, 2014.  All other long-term debt has floating interest rates, and its book value approximates its fair value as of the reporting date.

 

We use derivatives for hedging purposes.  As of November 30, 2014, our derivatives consist of foreign currency contracts. We determine the fair value of our derivative instruments based on Level 2 inputs in the fair value hierarchy. See Notes 7, 8, 11, and 14 for more information on our hedging activities.

 

The Company’s other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 assets. These assets are measured at fair value on a non-recurring basis as part of the Company’s impairment assessments and as circumstances require.  As discussed in Note 9, in connection with our annual impairment testing during the fiscal quarter ended May 31, 2014, we recorded a non-cash asset impairment charge of $9.00 million ($8.16 million after tax). The charge related to certain trademarks in our Personal Care segment, which were written down to their estimated fair value, determined on the basis of future discounted cash flows using the relief from royalty valuation method.